drugset / Trial / NCT04086940

Role of Intraoperative Beta Blocker for Morbid Obese Patients Undergoing Laparoscopic Bariatric Surgery

NCT04086940

Phase 4 Unknown 60 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Using esmolol during anesthetic maintenance of laparoscopic bariatric surgery significantly decreases anesthetic, analgesic requirements, postoperative pain, PNV and postoperative hypoxia.

Timeline

Start
2019-11
Primary completion
2019-11
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esmolol Other / unclassified 10 ug/kg

Indications

No indication recorded.